Preliminary Mesenchymal stem cells treatment reports on Covid-19 patients has shown promising results. Medical Tourism Corporation is helping facilitate this treatment in Mexico in COFEPRIS (Mexican FDA) approved facility.
With the positive results in stem cell treatment o7 patients with COVID-19 in the following
Patient Condition |
|
---|---|
Treatment |
|
Result |
|
Other studies that strengthen the stem cell approach for COVID-19:
Patient | Pre-treatment | Treatment | Post-treatment |
---|---|---|---|
1. Case Study on a female patient | Acute COVID19 syndrome | 21 days of treatment with umbilical cord MSCs | 1. Laboratory tests and CT images provided extremely effective results[2]Stem Cell Reviews and Reports Mesenchymal Stem Cell Therapy for COVID-19: Present or Future “a case study was reported in China on a female patient with an acute COVID19 syndrome that the results of laboratory tests and CT images provided extremely effective results after 21 days of treatment…” View in Article |
2. Case report on a 65-year-old female | COVID-19 induced acute pneumonia with abnormal neutrophils and diminished lymphocytes | Cord MSCs + α1 thymosin 5 × 107 cells, each three times |
|
Some ongoing and planned studies for Mesenchymal stem cells on COVID-19:
Phase | Patient Characteristics | Treatment | Country |
---|---|---|---|
Ongoing | Pneumonia Patients Infected With COVID-19 | I.V. transfusion one round (3 times) of 3.0*10E7 cells of MSCs[4]ClinicalTrials.gov Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 “Objective: To note improvement of Clinical symptoms and Side effects in the MSCs treatment group…” View in Article |
Beijing, China |
Planned | COVID-19 patients with lung inflammation | Umbilical cord-derived mesenchymal stem cells (UC-MSCs) | Miami, USA |
Planned | Coronavirus Induced Severe Pneumonia | Dental Pulp Mesenchymal Stem Cells[5]ClinicalTrials.gov Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells “Objective: To note the disappear time of ground-glass shadow in the lungs…” View in Article |
Shanghai, China |
MTC-Partner -Dr Anand Shrivastava, chairman and co-founder of Global Institute Of Stem cell Therapy And Research (GIOSTAR), explains how mesenchymal cells can treat Coronavirus affected patients.
Check out this video for more.
Stem cells are a broader term for different kind of cells present in the body. These have the ability to divide and differentiate into specialized cells like brain cells, blood cells, heart muscle cells or bone cells.
Stem cells are now being widely tested as a part of regenerative medicine. These have already been approved for the treatment of cancers of the blood and bone marrow. Many more diseases are being treated using stem cell therapy in Mexico which still need approval in the USA.
Apart from this, latest researches confirm that stem cells can be a potential treatment for are COVID-19 positive patient and have an underlying condition.
Mesenchymal cells are a kind of adult stem cells. These are capable of forming our skeletal tissues, such as cartilage, bone, and fat.
These cells can be found in the bone marrow, fat tissues, fallopian tube, peripheral blood cells, and in the umbilical cord cells and can be easily extracted from these sites.
The mesenchymal cells are known to boost human immunity.
With the 7-patient study, researchers are able to solidify the following inference:
No, mesenchymal cells do not pose any threat to the host’s body when transferred from a different donor. It owes to the immuno-suppressive properties of these cells [8]International Journal of Biomedical Sciences
The Immune Properties of Mesenchymal Stem Cells
“they also elicit immuno-suppressive effects that allow them to bypass allogeneic barriers …”
View in Article which does not initiate an antibody response in the host’s body.
COVID-19 is a new strain of the virus that belongs to the coronavirus family. The symptoms of COVID-19 infection are as follows:
COVID-19, officially known as Sars-CoV-2 does not cause the death of any person. The death is, however, caused by the body’s own immune response against this virus. The following procedure will shed some light on the mechanism.
On infection, the virus quickly moves to the windpipe or trachea and stays there for some time.
The person may not develop any symptoms at this time. This is called an infection. But, once the virus starts multiplying, symptoms may appear.[9]BBC
Coronavirus: What it does to the body
“It first infects the cells…infect yet more cells….”
View in Article.
The incubation period or the period between infection and appearance of the first symptom varies from one person to another, but generally, it is 5 days.
Once this virus enters the human body, the natural defence system of the body triggers an immune response.
This further releases certain chemicals called cytokines and chemokines in the body.
Due to these chemicals, lungs are inflamed and these experience an excessive fluid build-up[10]The Hindu
Coronavirus | How does the immune system respond to a coronavirus attack?
“In the nose and upper regions of the…prevent their ingress…”
View in Article. This fluid also houses T-cells which are potent natural killers. These TNKs, however, attack the body’s own cells along with killing the pathogens.
The significant symptom of Coronavirus infection-a dry cough is initiated. In this way, the lungs are trying to evacuate the mucous out of the body.
This cough is a potential carrier of the COVID-19 virus and proper social distancing and other precautions should be taken to stop the spread.
Meanwhile, the TNKs are attacking the healthy cells of the body. Slowly and gradually, the lungs become dis-functional and are unable to exchange oxygen with the blood, causing oxygen stress.
The continuous lack of oxygen causes the death of the infected patient.
It is observed that the mortality rate of old people, as well as patients with severe underlying conditions like Type-2 diabetes or chronic lung disease, is high due to coronavirus-related symptoms. [11]Centres for Disease Control and Prevention
People Who Are at Higher Risk for Severe Illness
“Based on what we know now, those at high-risk…particularly if not well controlled …”
View in Article
There are many other reasons why Mexico is the best place for receiving mesenchymal stem cell treatment for COVID-19 infection.
Using stem cell to treat different diseases is a legalised procedure in Mexico. Also, the Mexican government is very flexible in using novel scientific research like Mesenchymal cells in COVID-19 patients.
This is, however, not true for the USA as stem cell technology is not approved by the US-FDA.
Our partner clinic has scientists working on stem cell technology for more than 12 years. They are licensed physicians and are authorized to treat patients using human cells.
Our partner clinic has already applied for IND approval by the US-FDA for stem cells in Type-2-Diabetes patients.[12]Giostar
GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial
“in the process of approval from the United States Food and Drug Administration (FDA) to conduct type 2 diabetes clinical trials focused on the development of stem cell-based treatment.”
View in Article
Our partner clinic has branches in Los Algodones and Playa del Carman- Cancun Riviera. Both of these locations are near the US Border and one can easily cross the US-Mexico border.
Note: The border is open for travel related to essential services including medical reasons.
MTC has been aiding medical and dental tourism to clients from all over the world. There are many reasons why you should choose us for your treatment with Stem Cells for Coronavirus in Mexico:
Contact us for more information on medical tourism.
Our partner clinic has been treating patients suffering from different diseases with stem cells in their Mexico based centres. Some of these diseases are mentioned below:
*Please review our full disclaimers, Terms & Conditions and, Health Privacy & Confidentiality Statement. Individual results may vary. The statements on this website have not been evaluated by the FDA or any medical professional.